- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03253393
Smart Touch Non-dispensing Handling Studies
Microbial Contamination Rates on the Back Surface of Soft Contact Lenses in Two Short-term, Randomized, Contralateral Non-dispensing Studies
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This will be a prospective, single centre, randomized, contralateral, investigator-masked non-dispensing study. This study requires three visits of approx. 1 hour duration each.
At the first visit, the order in which the hydrogel (no EDTA) and silicone hydrogel (with EDTA) contact lenses are allocated to the study participants will be randomized. At the second visit, participants will be crossed over to the alternate lens type (hydrogel no EDTA or silicone hydrogel with EDTA).
At the third visit, participants will be randomly allocated to wear the hydrogel lens (with EDTA) in one eye and the silicone hydrogel lens (no EDTA) in the other eye, both removed from Smart Touch Technology packaging.
At each visit, participants will be instructed to:
- Wash their hands prior to handling the contact lenses;
- Swab their thumb and two index fingers of the hand routinely used to conduct contact lens insertion using a sterile cotton swab moistened with sterile preservative free saline for the evaluation of skin microbiota;
- Follow the manufacturer's guidelines for lens insertion;
- Open the blister pack and insert the contact lens randomly assigned for the right eye;
- Open the blister pack and insert the contact lens assigned for the left eye;
- Contact lenses will be removed aseptically by a masked investigator after 45 minutes of lens wear.
Lenses and finger swabs will be analysed for microbial contamination using established routine microbiology protocols. The number and species of organisms will be determined.
A minimum washout period of 48 hours will occur between the study visits.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New South Wales
-
Sydney, New South Wales, Australia, 2052
- School of Optometry and Vision Science
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Able to read and comprehend English and give informed consent as demonstrated by signing a Participant Information Statement and Consent Form;
- Be at least 18 years old;
- Experienced soft contact lens wearer;
- Willing to refrain from wearing contact lenses for 24 hours prior to the scheduled study visit
Exclusion Criteria:
- Under 18 years old;
- Have any active corneal infection, ocular disease or systemic disease that would affect wearing of contact lenses;
- Use or have a need for any systemic or topical medications which may alter normal ocular findings/are known to affect a participant's ocular health/physiology either in an adverse manner or risk providing a false positive;
- Have had eye surgery within 12 weeks immediately prior to enrolment for this trial;
- Have contraindications to contact lens wear;
- Have a greater than 2 line reduction in habitual visual acuity while wearing the study contact lenses;
- Be currently enrolled in another clinical trial;
- Be pregnant (verbal self-report)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Silicone hydrogel (with EDTA) in Smart Touch vs. in conventional packaging
|
hioxifilcon A contact lens in Smart Touch Technology (hydrogel, no EDTA) midafilcon A contact lens in Smart Touch Technology (silicone hydrogel, with EDTA)
hioxifilcon A contact lens in conventional lens packaging (hydrogel, no EDTA) midafilcon A contact lens in conventional lens packaging (silicone hydrogel, with EDTA)
|
|
Experimental: Hydrogel (no EDTA) in Smart Touch vs. in conventional packaging
|
hioxifilcon A contact lens in Smart Touch Technology (hydrogel, no EDTA) midafilcon A contact lens in Smart Touch Technology (silicone hydrogel, with EDTA)
hioxifilcon A contact lens in conventional lens packaging (hydrogel, no EDTA) midafilcon A contact lens in conventional lens packaging (silicone hydrogel, with EDTA)
|
|
Experimental: Silicone hydrogel (no EDTA) vs. hydrogel (with EDTA) in Smart Touch
|
hioxifilcon A contact lens in Smart Touch Technology (hydrogel, with EDTA) midafilcon A contact lens in Smart Touch Technology (silicone hydrogel, no EDTA)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Without Contamination of Contact Lenses
Time Frame: After 45 minutes of lens wear
|
Number of Participants Without Contamination of Contact Lenses after 45 minutes of wear
|
After 45 minutes of lens wear
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bacterial Counts of Worn Contact Lenses
Time Frame: After 45 minutes of lens wear
|
Bacterial counts of contact lenses after 45 minutes of wear (CFU count /lens)
|
After 45 minutes of lens wear
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SOVS2017-050
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Optometry
-
He Eye HospitalCompleted
-
Reza RastmaneshEnrolling by invitationDepression | Anxiety | Sleep Deprivation | Gut Microbiota | Oral Microbiota | Optometry ExaminationsIran, Islamic Republic of
Clinical Trials on Smart Touch Technology packaging
-
University of California, San FranciscoRecruiting
-
LMU KlinikumCompletedPersistent Atrial FibrillationGermany
-
KK Women's and Children's HospitalRecruiting
-
Moscow Scientific and Practical Center of Medical...RecruitingStroke RehabilitationRussian Federation
-
University of Wisconsin, MadisonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruitingAlcohol Use Disorder | Alcohol Use Disorder (AUD)United States
-
University of South FloridaU.S. Army Medical Research Acquisition ActivityUnknownComplications of the Amputated LimbUnited States
-
University of British ColumbiaVancouver Coastal Health Research Institute; GF Strong Rehabilitation CentreCompletedUnilateral Trans Tibial/Femoral Lower Limb AmputationCanada
-
Bruyere Research InstituteUniversity of Ottawa; Bruyere Academic Medical Organization; TOTO USAUnknown
-
Medical University of South CarolinaKwame Nkrumah University of Science and TechnologyCompleted
-
Public Health Foundation Enterprises, Inc.TerminatedAdherence | HIV Pre-exposure Prophylaxis | Mobile Health Technology (mHealth) | HIV Prevention and Care | Doxycycline STI PEPUnited States